Citation: Hz. Ke et al., Lasofoxifene (CP-336,156) protects against the age-related changes in bonemass, bone strength, and total serum cholesterol in intact aged male rats, J BONE MIN, 16(4), 2001, pp. 765-773
Authors:
Ke, HZ
Qi, H
Crawford, DT
Chidsey-Frink, KL
Simmons, HA
Thompson, DD
Citation: Hz. Ke et al., Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat, ENDOCRINOL, 141(4), 2000, pp. 1338-1344
Authors:
Ke, HZ
Crawford, DT
Qi, H
Pirie, CM
Simmons, HA
Chidsey-Frink, KL
Chen, HK
Jee, WSS
Thompson, DD
Citation: Hz. Ke et al., Droloxifene does not blunt bone anabolic effects of prostaglandin E-2, butmaintains prostaglandin E-2-restored bone in aged, ovariectomized rats, BONE, 24(1), 1999, pp. 41-47